Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial (Q38849442)
Jump to navigation
Jump to search
scientific article published on 3 April 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial |
scientific article published on 3 April 2017 |
Statements
1 reference
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial (English)
1 reference
Alberto Papi
Massimo Corradi
Viktor Blazhko
Isabella Montagna
Catherine Francisco
Géraldine Cohuet
Stefano Vezzoli
Mario Scuri
3 April 2017
1 reference